Qube Research & Technologies (QRT)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.3M Sell
1,506,100
-537,300
-26% -$14.3M 0.05% 494
2025
Q4
$50.9M Sell
2,043,400
-344,800
-14% -$8.69M 0.05% 490
2025
Q3
$60.9M Sell
2,388,200
-751,000
-24% -$18.5M 0.06% 387
2025
Q2
$76.1M Buy
3,139,200
+1,595,800
+103% +$37.2M 0.08% 328
2025
Q1
$39.1M Sell
1,543,400
-59,200
-4% -$1.55M 0.05% 489
2024
Q4
$42.5M Sell
1,602,600
-635,500
-28% -$17.2M 0.06% 431
2024
Q3
$64.8M Buy
2,238,100
+1,671,700
+295% +$48.8M 0.1% 270
2024
Q2
$15.8M Buy
566,400
+39,300
+7% +$1.08M 0.03% 710
2024
Q1
$14.6M Buy
527,100
+356,500
+209% +$9.89M 0.02% 685
2023
Q4
$4.91M Buy
170,600
+51,600
+43% +$1.56M 0.01% 1049
2023
Q3
$3.95M Buy
+119,000
New +$4.21M 0.01% 1052
2023
Q1
Sell
-200,000
Closed -$10.2M 2904
2022
Q4
$10.2M Buy
+200,000
New +$9.59M 0.05% 481

Other funds holding PFE

Qube Research & Technologies (QRT)'s PFE Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Pfizer (PFE) in Q4 2025, closing a stake of 160,523 shares — an estimated $4.05M sold.

Qube Research & Technologies (QRT) first reported a position in PFE in Q1 2018 and held it in 25 quarters. The position peaked at $271M in Q1 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 160,523 Pfizer shares in Q4 2025, an estimated $4.05M.
  • Qube Research & Technologies (QRT) first reported a position in Pfizer in Q1 2018 and held it in 25 quarters.
  • Qube Research & Technologies (QRT)'s Pfizer position peaked at $271M in Q1 2025.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.